Andrew Lawrence Taylor bought $4,830 of OBIO
Chief Financial Officer at Orchestra BioMed Holdings, Inc.. 1,000 shares at an average of $4.83, traded Dec 19, 2024, filed Dec 20, 2024.
Score components
- +22RoleCFO
- 0Trade size$5k at market
- -5Relative to holdingsUnder 1% of holdings (0.3%)
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-130521, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 19, 2024 | POpen-market purchase Common Stock, par value $0.0001 per share | +1,000 | $4.83 | $4,830 | 344,960 | Dec 20, 2024 |
Related signals
Other insiders at Orchestra BioMed Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $95k 15,000 shares | -1% | |
| 17Weak | OBIObuy Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $48k 10,000 shares | +1% | |
| 3Weak | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $74k 15,000 shares | -1% | |
| 23Weak | OBIObuy Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $20k 5,000 shares | +1% | |
| 28Weak | OBIObuy Orchestra BioMed Holdings, Inc. | Jason Aryeh director | $2,450 1,000 shares | +1% | |
| 51Moderate | Orchestra BioMed Holdings, Inc. | Eric S Fain director | $15k 5,760 shares | +9% | |
| 48Moderate | Orchestra BioMed Holdings, Inc. | David P Hochman See Remarks | $15k 6,000 shares | +1% | |
| 50Moderate | Orchestra BioMed Holdings, Inc. | Andrew Lawrence Taylor Chief Financial Officer | $5,100 2,000 shares | +0% | |
| 43Moderate | Orchestra BioMed Holdings, Inc. | Darren Sherman See Remarks | $7,860 3,000 shares | +0% | |
| 61Notable | Orchestra BioMed Holdings, Inc. | Perceptive Advisors LLC owner | $1.9M 700,000 shares | +15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.